Integrated Proteins Limited reported a standalone net profit of ₹36.26 lakh for the quarter ended June 30, 2026, marking a substantial recovery from the near-zero profit of ₹0.01 lakh recorded in the same period last year. Revenue from operations expanded by 8.8% year-on-year to ₹1,056.38 lakh, up from ₹971.07 lakh in Q1FY25.

The company’s profitability improved sharply as pre-tax profits rose to ₹48.45 lakh from ₹0.01 lakh in the prior year. This operational turnaround was supported by higher top-line growth, with revenue also increasing 88.5% quarter-on-quarter compared to ₹560.53 lakh in Q4FY25.

Financial Performance

The Board of Directors approved the unaudited standalone financial results at a meeting held on August 14, 2026. The figures were reviewed by the Audit Committee and prepared in accordance with Indian Accounting Standard (Ind AS) 34.

Earnings per share (basic and diluted) stood at ₹0.19 for the quarter, compared to ₹0.00 in the corresponding period of the previous fiscal year. For the full year ended March 31, 2026, the company reported a net profit of ₹22.50 lakh on revenue of ₹994.07 lakh.

What the Numbers Show

The divergence between revenue growth and profit expansion highlights a significant improvement in cost efficiency or margin structure. While revenue grew moderately by 8.8% year-on-year, pre-tax profits surged over 48,000 times, suggesting that fixed costs were better absorbed or variable costs declined significantly relative to sales volume. This indicates a potential inflection point in operational leverage for the protein processing business.

Integrated Proteins Limited has scheduled an Extraordinary General Meeting (EGM) for August 20, 2026, to approve a 1:10 sub-division of its equity shares, aiming to enhance market liquidity and broaden investor accessibility. The company will also seek shareholder consent to regularize the appointments of two directors, including the re-appointment of its Chairman and Managing Director, Hiren Dhirajlal Shah, for a five-year term. This structural adjustment allows retail investors easier entry by lowering the absolute price point per share, although total market capitalization remains unchanged.

The EGM will be conducted through Video Conferencing or Other Audio-Visual Means (VC/OAVM), in compliance with Ministry of Corporate Affairs (MCA) General Circulars No. 03/2025 and subsequent directives permitting virtual meetings. The meeting is scheduled to begin at 1:00 P.M. on August 20, 2026. Shareholders holding shares as on the record date of August 13, 2026, are eligible to vote. Remote e-voting facilities will be available from August 17, 2026, at 9:00 A.M. to August 19, 2026, at 5:00 P.M., facilitated by National Securities Depository Limited (NSDL).

Share Sub-Division and Capital Alteration

The primary agenda item involves the sub-division of existing equity shares with a face value of ₹10 into ten equity shares with a face value of ₹1 each. This stock split will not alter the aggregate amount of the company’s authorized, issued, subscribed, and paid-up share capital, which remains at ₹25,00,00,000 (₹25 crore). Consequently, the authorized share capital structure will change from 2,50,00,000 shares of ₹10 each to 25,00,00,000 shares of ₹1 each.

The Board of Directors approved this proposal on July 9, 2026, subject to shareholder approval and necessary regulatory consents from BSE Limited. The company will apply for new International Securities Identification Numbers (ISINs) for the subdivided shares from NSDL and Central Depository Services (India) Limited (CDSL). Physical share certificates will be deemed cancelled, and new certificates or confirmation letters will be issued by the Registrar and Share Transfer Agent (RTA), Cameo Corporate Services Limited, without requiring members to surrender existing certificates.

Director Regularizations

Shareholders will also vote on two director-related resolutions:

• Nitish Pratapray Mehta: Regularization as a Non-Executive Non-Independent Director. Mr. Mehta was appointed as an Additional Director on July 9, 2026, and holds office until the date of this EGM. His regularization is required under Section 161 of the Companies Act, 2013.
• Hiren Dhirajlal Shah: Re-appointment as Chairman and Managing Director for a term of five years, from July 24, 2026, to July 23, 2031. This appointment requires a Special Resolution under Regulation 17(1C) of the SEBI Listing Regulations. His remuneration includes a basic salary of ₹96,000 per annum, along with perquisites such as housing allowance and special allowances.

What the Numbers Show

The proposed 1:10 share split is a structural adjustment rather than a financial expansion. By reducing the face value from ₹10 to ₹1, Integrated Proteins aims to lower the absolute price point of its shares, potentially attracting retail investors who may find the previous pricing tier less accessible. The total market capitalization remains unchanged by the split itself; however, increased share count may influence trading volume and liquidity metrics in the secondary market. The simultaneous regularization of leadership roles suggests a focus on governance stability alongside these capital structure changes.